Do you want to read an article? Please log in or register.
FEV(1) Decline and Clinical Predictors in Asthma after 10 Years of Follow-Up: BMI as a Modifiable Risk Factor
Asthma
Related content
RECOMMENDED
Asthma
Inflammatory and clinical risk factors for asthma attacks (ORACLE2): a patient-level meta-analysis of control groups of 22 randomised trials
★ 3
Recommended by
Dr Martin Frey, Faculty Member
Lancet Respir Med
Meulmeester FL, Mailhot-Larouche S, Celis-Preciado C, Lemaire-Paquette S, Ramakrishnan S, Wechsler ME, Brusselle G, Corren J, Hardy J, Diver SE, Brightling CE, Castro M, Hanania NA, Jackson DJ, Martin N, Laugerud A, Santoro E, Compton C, Hardin ME, Holweg CTJ, Subhashini A, Hinks TSC, Beasley RW, Sont JK, Steyerberg EW, Pavord ID, Couillard S
doi: 10.1016/S2213-2600(25)00037-2
COMMENTED
Asthma
XALOC-1: Clinical remission over 2-years with benralizumab in severe eosinophilic asthma
★ 3
Recommended and commented by
Dr Marcus Hesse, Faculty Member
Chest
Pelaia G, Jackson DJ, Nair P, Emmanuel B, Tran TN, Menzies-Gow A, Watt M, Kayaniyil S, Boarino S, Nuevo J, Pardal M, Shavit A, Shih VH, Cohen D, Loureiro C, Padilla-Galo A
doi: 10.1016/j.chest.2025.04.011
RECOMMENDED
Asthma
Clinical response and on-treatment clinical remission with tezepelumab in a broad population of patients with severe, uncontrolled asthma: results over 2 years from the NAVIGATOR and DESTINATION studies
★ 3
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Eur Respir J
Wechsler ME, Brusselle G, Virchow JC, Bourdin A, Kostikas K, Llanos JP, Roseti SL, Ambrose CS, Hunter G, Jackson DJ, Castro M, Lugogo N, Pavord ID, Martin N, Brightling CE
doi: 10.1183/13993003.00316-2024
RECOMMENDED
Asthma
The Real-World Impact of Glucagon-Like Peptide 1 Receptor Agonists on Asthma Control in People with High-Risk Asthma and Obesity
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Adv Ther
Kaplan A, Heatley H, Townend J, Skinner D, Carter V, Hubbard R, Lee TT, Koh MS, Price D
doi: 10.1007/s12325-025-03175-x
RECOMMENDED
Asthma
Long-Term Clinical Remission on Benralizumab Treatment in Severe Eosinophilic Asthma: A Four-Year Real-Life Study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
J Clin Med
Quarato CMI, Tondo P, Lacedonia D, Soccio P, Pescatore D, Baccellieri ML, Lepore G, Foschino Barbaro MP, Scioscia G
doi: 10.3390/jcm14062075
Asthma
Risk Factors for Hospitalization in Subspecialty Patients with Severe Persistent Asthma
Respir Med
Seshadri N, Faig W, Young LR, Hill DA
doi: 10.1016/j.rmed.2024.107867
COPD
A Two-Staged, Risk-Stratified Strategy Combining FEV(1)/FEV(6) and COPD Diagnostic Questionnaire Acts as an Accurate and Cost-Effective COPD Case-Finding Method
Respirology
Lo PC, Ko HK, Chou KT, Hsiao YH, Perng DW, Su KC
doi: 10.1111/resp.70000
RECOMMENDED
Lung Cancer
Patterns and preoperative risk factors of occult lymph node metastasis in clinical stage I lung cancer
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Lung Cancer
Yang YH, Kim HE, Park BJ, Lee JG, Kim DJ, Lee CY
doi: 10.1016/j.lungcan.2025.108461
RECOMMENDED
Asthma
Integrated nasopharyngeal airway metagenome and asthma genetic risk endotyping of severe bronchiolitis in infancy and risk of childhood asthma
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Eur Respir J
Zhu Z, Shibata R, Hoffman KL, Cormier J, Mansbach JM, Liang L, Camargo CA, Hasegawa K
doi: 10.1183/13993003.01130-2024